Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Aug;76(2):723–730. doi: 10.1172/JCI112027

Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G subclasses in rheumatoid arthritis.

J E Persselin, R H Stevens
PMCID: PMC423887  PMID: 3928684

Abstract

Isoelectric focusing analyses of sera from patients with rheumatoid arthritis (RA) demonstrate two populations of antibodies directed against the Fab portion of pooled human IgG. One population is composed of polyclonal alkaline anti-Fab antibodies (alpha FABA) and the other, acidic alpha FABA which are more clonally restricted. In this study we have identified the immunoglobulin classes and subclasses of these antibodies in RA sera. Enzyme-linked immunosorbent assays (ELISA) demonstrated alpha FABA in RA sera to be predominantly IgG. A large portion of IgG alpha FABA existed as immune complexes, inasmuch as dialysis of RA sera against 6 M urea before ELISA analysis was necessary for maximal detection of alpha FABA activity. Chromatofocusing of RA sera isolated alpha FABA of different charges and revealed the acidic clonally restricted alpha FABA to be IgG4 and IgG3, whereas the polyclonal alkaline group contained IgG1, IgG2, and IgG3. Overall, acidic IgG3 and IgG4 comprised 70% of IgG alpha FABA, and high levels of IgG4 were seen in most RA sera. When alpha FABA were elevated in normal sera, they were primarily of the IgG4 subclass, and also existed as immune complexes. Serum anti-Fab activity was removed by adsorption of sera with Fab fragments. Anti-Fab antibodies of both kappa and lambda light-chain types were present in RA sera, and F(ab')2 fragments of RA serum immunoglobulin were found to possess anti-Fab activity. These studies indicate that alpha FABA in RA sera are limited to the IgG class, and that most of these antibodies exist as immune complexes and display clonal and minor IgG subclass restriction.

Full text

PDF
723

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdou N. I., Wall H., Lindsley H. B., Halsey J. F., Suzuki T. Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. J Clin Invest. 1981 May;67(5):1297–1304. doi: 10.1172/JCI110158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen C., Elson C. J., Scott D. G., Bacon P. A., Bucknall R. C. IgG antiglobulins in rheumatoid arthritis and other arthritides: relationship with clinical features and other parameters. Ann Rheum Dis. 1981 Apr;40(2):127–131. doi: 10.1136/ard.40.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Birdsall H. H., Lidsky M. D., Rossen R. D. Anti-Fab' antibodies in rheumatoid arthritis. Measurement of the relative quantities incorporated in soluble immune complexes in sera and supernatants from cultured peripheral blood lymphocytes. Arthritis Rheum. 1983 Dec;26(12):1481–1492. doi: 10.1002/art.1780261210. [DOI] [PubMed] [Google Scholar]
  4. Birdsall H. H., Rossen R. D. Characterization of anti-Fab' antibodies in human sera: identification of soluble immune complexes that contain hidden anti-KLH and blocking anti-immunoglobulins following immunization with keyhole limpet haemocyanin. Clin Exp Immunol. 1983 Aug;53(2):497–504. [PMC free article] [PubMed] [Google Scholar]
  5. Carson D. A., Pasquali J. L., Tsoukas C. D., Fong S., Slovin S. F., Lawrance S. K., Slaughter L., Vaughan J. H. Physiology and pathology of rheumatoid factors. Springer Semin Immunopathol. 1981;4(2):161–179. doi: 10.1007/BF01857093. [DOI] [PubMed] [Google Scholar]
  6. Cunningham-Rundles C. Naturally occurring autologous anti-idiotypic antibodies. Participation in immune complex formation in selective IgA deficiency. J Exp Med. 1982 Mar 1;155(3):711–719. doi: 10.1084/jem.155.3.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Davey M. P., Korngold L. Association of anti-F (ab')2 antibodies (pepsin agglutinators) with immune complexes as determined by enzyme-linked immunosorbent assays. Int Arch Allergy Appl Immunol. 1982;67(3):278–283. doi: 10.1159/000233031. [DOI] [PubMed] [Google Scholar]
  8. FAHEY J. L. TWO TYPES OF 6.6 S GAMMA-GLOBULINS, BETA-2A-GLOBULINS AND 18 S GAMMA 1-MACROGLOBULINS IN NORMAL SERUM AND GAMMA-MICROGLOBULINS IN NORMAL URINE. J Immunol. 1963 Oct;91:438–447. [PubMed] [Google Scholar]
  9. Geha R. S. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen. J Immunol. 1982 Jul;129(1):139–144. [PubMed] [Google Scholar]
  10. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  11. Heimer R., Wolfe L. D., Abruzzo J. L. IgM and IgG anti-F(ab')2 antibodies in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1298–1306. doi: 10.1002/art.1780251105. [DOI] [PubMed] [Google Scholar]
  12. Hurd E. R. Extraarticular manifestations of rheumatoid arthritis. Semin Arthritis Rheum. 1979 Feb;8(3):151–176. doi: 10.1016/s0049-0172(79)80005-0. [DOI] [PubMed] [Google Scholar]
  13. Johnson P. M., Faulk W. P. Rheumatoid factor: its nature, specificity, and production in rheumatoid arthritis. Clin Immunol Immunopathol. 1976 Nov;6(3):414–430. doi: 10.1016/0090-1229(76)90094-5. [DOI] [PubMed] [Google Scholar]
  14. KUNKEL H. G., MULLER-EBERHARD H. J., FUDENBERG H. H., TOMASI T. B. Gamma globulin complexes in rheumatoid arthritis and certain other conditions. J Clin Invest. 1961 Jan;40:117–129. doi: 10.1172/JCI104224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ling N. R., Drysdale P. Antibodies in human sera to F(ab')2 fragments of monoclonal and polyclonal IgG. Int Arch Allergy Appl Immunol. 1981;66(4):459–463. doi: 10.1159/000232854. [DOI] [PubMed] [Google Scholar]
  16. Mellbye O. J., Natvig J. B. Evidence for immune complexes containing antibody to the pepsin site of IgG in rheumatoid synovial fluids. Clin Exp Immunol. 1971 Jun;8(6):889–899. [PMC free article] [PubMed] [Google Scholar]
  17. Morrow C. D., Dorey F., Stevens R. H. Isoelectric focusing of human anti-diphtheria toxoid antibodies: identical spectrotypes of anti-fragment A antibodies with the same IgG subclass and light chain constant regions are expressed in multiple individuals. J Immunol. 1983 Feb;130(2):818–823. [PubMed] [Google Scholar]
  18. Morrow C. D., Macy E. M., Stevens R. H. Analysis of human anti-diphtheria antibodies by isoelectric focusing: evidence for restricted clonal heterogeneity of anti-fragment A antibodies. Infect Immun. 1981 Mar;31(3):1132–1137. doi: 10.1128/iai.31.3.1132-1137.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Munthe E., Natvig J. B. Immunglobulin classes, subclasses and complexes of IgG rheumatoid factor in rheumatoid plasma cells. Clin Exp Immunol. 1972 Sep;12(1):55–70. [PMC free article] [PubMed] [Google Scholar]
  20. Müller-Eberhard H. J. Chemistry and reaction mechanisms of complement. Adv Immunol. 1968;8:1–80. doi: 10.1016/s0065-2776(08)60464-2. [DOI] [PubMed] [Google Scholar]
  21. NISONOFF A. ENZYMATIC DIGESTION OF RABBIT GAMMA GLOBULIN AND ANTIBODY AND CHROMATOGRAPHY OF DIGESTION PRODUCTS. Methods Med Res. 1964;10:134–141. [PubMed] [Google Scholar]
  22. Nasu H., Chia D. S., Knutson D. W., Barnett E. V. Naturally occurring human antibodies to the F(ab')2 portion of IgG. Clin Exp Immunol. 1980 Nov;42(2):378–386. [PMC free article] [PubMed] [Google Scholar]
  23. Nasu H., Chia D. S., Taniguchi O., Barnett E. V. Characterization of anti-F(ab')2 antibodies in SLE patients. Evidence for cross-reacting auto-anti-idiotypic antibodies. Clin Immunol Immunopathol. 1982 Oct;25(1):80–90. doi: 10.1016/0090-1229(82)90167-2. [DOI] [PubMed] [Google Scholar]
  24. OSTERLAND C. K., HARBOE M., KUNKEL H. G. Anti-gamma-globulin factors in human sera revealed by enzymatic splitting of anti-Rh antibodies. Vox Sang. 1963 Mar-Apr;8:133–152. doi: 10.1111/j.1423-0410.1963.tb03290.x. [DOI] [PubMed] [Google Scholar]
  25. Persselin J. E., Louie J. S., Stevens R. H. Clonally restricted anti-IgG antibodies in rheumatoid arthritis. Arthritis Rheum. 1984 Dec;27(12):1378–1386. doi: 10.1002/art.1780271208. [DOI] [PubMed] [Google Scholar]
  26. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  27. Rosén A., Ek K., Aman P. Agarose isoelectric focusing of native human immunoglobulin M and alpha 2-macroglobulin. J Immunol Methods. 1979;28(1-2):1–11. doi: 10.1016/0022-1759(79)90322-3. [DOI] [PubMed] [Google Scholar]
  28. Voller A., Bidwell D. E., Bartlett A. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ. 1976;53(1):55–65. [PMC free article] [PubMed] [Google Scholar]
  29. Williams R. C., Kunkel H. G. Observations on antigamma globulin factors in human sera and antibodies against autologous gamma globulins produced in rabbits. Ann N Y Acad Sci. 1965 Jun 30;124(2):860–864. doi: 10.1111/j.1749-6632.1965.tb19008.x. [DOI] [PubMed] [Google Scholar]
  30. Winchester R. J., Agnello V., Kunkel H. G. Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels. Clin Exp Immunol. 1970 May;6(5):689–706. [PMC free article] [PubMed] [Google Scholar]
  31. Zubler R. H., Nydegger U., Perrin L. H., Fehr K., McCormick J., Lambert P. H., Miescher P. A. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease. J Clin Invest. 1976 May;57(5):1308–1319. doi: 10.1172/JCI108399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Zvaifler N. J. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol. 1973;16(0):265–336. doi: 10.1016/s0065-2776(08)60299-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES